MedTrace Logo

Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR

NCT02778802 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-01-04

No results posted yet for this study

Summary

This study is designed as a prospective study, with the primary endpoint being changes in pulmonary hemodynamic parameters after ELVR in patients with severe emphysema.

Secondary endpoints will be changes in lung function parameters, exercise capacity, and QoL.

Conditions

  • Pulmonary Hypertension
  • Chronic Obstructive Lung Disease

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed A Elnady, MD · Professor of pulmonary Medicine ,Cairo University

  • Karim Mahmoud, MD · Lecturer of cardiology ,Cairo University

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02778802 on ClinicalTrials.gov